Company Data

NGM Biopharmaceuticals Inc.

Ticker
NGM
Current Price
$1.54
Market Cap
$128.5M
Price Target
Refer to Report
Volume
21.0K
52wk Range
$0.6002 - $2.515
Advanced Market Data

Overview

NGM Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics based on scientific understanding of key biological pathways for the treatment of cardio-metabolic, liver, oncologic and ophthalmic diseases. The company’s products include NGM282 (aldafermin), NGM313 (MK-3655), NGM120, NGM120, NGM621, and NGM395, all these are focused on NASH, diabetes, oncology, AMD and metabolic disease.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy